Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics Workshop on Evaluating RWE from Observational Studies in Regulatory Decision-Making FDA Real-World Evidence Reinforced EU/US collaboration on medicines European Medicines Agency (EMA) Human Scientific Committees' Working Parties with Patients' and Consumers' Organisations (PCWP) and Healthcare Professionals' Organisations (HCPWP) joint meeting A vision for use of real-world evidence in EU medicines regulation Sixth industry stakeholder platform on research and development support Learnings initiative webinar for optimal use of big data for regulatory purpose Real-world evidence (RWE) Navigator EMA Health Canada Strengthening the use of real world evidence for drugs Strengthening the use of real world evidence and regulations for medical devices Elements of Real World Data/Evidence Quality throughout the Prescription Drug Product Life Cycle Optimizing the Use of Real World Evidence to Inform Regulatory Decision-Making PMDA Department of Health